Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classement en actions #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Prix de l'action
$0.16328419
Capitalisation boursière
$204.14K
Changement (1 jour)
4.35%
Changement (1 an)
102.45%
Pays
GB
Échange Fusion Antibodies plc (FAB)

Catégorie

Historique du prix de l'action pour Fusion Antibodies plc (FAB)
Prix de clôture le plus élevé : $0.17 le 2026-03-01

Prix de clôture le plus bas : $2.40 le 2017-12-01
Historique du prix de l'action de Fusion Antibodies plc de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -21.78%
2025 153.61%
2024 38.42%
2023 -88.93%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$36.82 -51.12%
DK
$451.24 -11.82%
US
$736.53 11.43%
US
$294.88 52.33%
BE
$681.85 12.16%
NL